Director dealings: Redx Pharma CEO ups stake

12th Apr 2024 15:35

(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Anson, who was appointed to the board of Redx in 2018, purchased the shares on Thursday at an average price of 7.50p each, for a total value of £29,925.00.

Following the purchase, Anson holds 562,183 ordinary Redx shares, representing 0.14% of the company's issued share capital.

As of 1620 BST, Redx shares were up 6.67% at 8.0p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Redx Pharma (REDX)

Director name: Anson,Lisa

Amount purchased: 399,000 @ 7.50p

Value: £29,925.00

Zinnwald Lithium (ZNWD)

Director name: du Plessis,Anton

Amount purchased: 354,000 @ 5.61p

Value: £19,852.32

Zinnwald Lithium (ZNWD)

Director name: Rifaat,Cherif

Amount purchased: 337,792 @ 5.61p

Value: £18,946.75

Conduit Holdings Limited Com Shs (di) (CRE)

Director name: Carvey,Trevor

Amount purchased: 2,009 @ 497.00p

Value: £9,984.73

Conduit Holdings Limited Com Shs (di) (CRE)

Director name: Carvey,Trevor

Amount purchased: 2,013 @ 496.00p

Value: £9,984.48

Top Director Sells

Taseko Mines Limited Npv (di) (TKO)

Director name: Dickinson,Robert

Amount sold: 500,000 @ 336.00p

Value: £1,679,999.95

Just Group (JUST)

Director name: Richardson,David

Amount sold: 599,854 @ 102.30p

Value: £613,650.64

Netcall (NET)

Director name: Jackson,Michael

Amount sold: 180,951 @ 90.00p

Value: £162,855.90

Zinnwald Lithium (ZNWD)

Director name: du Plessis,Anton

Amount sold: 354,000 @ 5.60p

Value: £19,824.00

Zinnwald Lithium (ZNWD)

Director name: Rifaat,Cherif

Amount sold: 337,792 @ 5.60p

Value: £18,916.35